Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Trivella, D. B. B.
  • Bleicher, L.
  • Palmieri, L. D.
  • Wiggers, H. J.
  • Montanari, C. A.
  • Kelly, Jeffery
  • Lima, Lmtr
  • Foguel, D.
  • Polikarpov, I.

publication date

  • June 2010

journal

  • Journal of Structural Biology  Journal

abstract

  • Transthyretin (TTR) is a tetrameric beta-sheet-rich transporter protein directly involved in human amyloid diseases. It was recently found that the isoflavone genistein (GEN) potently inhibits TTR amyloid fibril formation (Green et al., 2005) and is therefore a promising candidate for TTR amyloidosis treatment. Here we used structural and biophysical approaches to characterize genistein binding to the wild type (TTRwt) and to its most frequent amyloidogenic variant, the V30M mutant. In a dose-dependent manner, genistein elicited considerable increases in both mutant and TTRwt stability as demonstrated by high hydrostatic pressure (HHP) and acid-mediated dissociation/denaturation assays. TTR:GEN crystal complexes and isothermal titration calorimetry (ITC) experiments showed that the binding mechanisms of genistein to the TTRwt and to V30M are different and are dependent on apoTTR structure conformations. Furthermore, we could also identify potential allosteric movements caused by genistein binding to the wild type TTR that explains, at least in part, the frequently observed negatively cooperative process between the two sites of TTRwt when binding ligands. These findings show that TTR mutants may present different ligand recognition and therefore are of value in ligand design for inhibiting TTR amyloidosis.

subject areas

  • Allosteric Site
  • Amino Acid Substitution
  • Amyloid
  • Amyloidosis
  • Crystallography, X-Ray
  • Genistein
  • Humans
  • Hydrogen-Ion Concentration
  • Hydrostatic Pressure
  • In Vitro Techniques
  • Ligands
  • Models, Molecular
  • Mutant Proteins
  • Prealbumin
  • Protein Binding
  • Protein Conformation
  • Protein Stability
  • Protein Structure, Quaternary
  • Recombinant Proteins
  • Thermodynamics
scroll to property group menus

Research

keywords

  • Crystal structure
  • Genistein
  • Isothermal titration calorimetry
  • Pressure stability
  • V30M mutant TTR
  • Wild type TTR
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1047-8477

Digital Object Identifier (DOI)

  • 10.1016/j.jsb.2010.03.002

PubMed ID

  • 20211733
scroll to property group menus

Additional Document Info

start page

  • 522

end page

  • 531

volume

  • 170

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support